Literature DB >> 15350294

Nanoparticle and targeted systems for cancer therapy.

Lisa Brannon-Peppas1, James O Blanchette.   

Abstract

This review explores recent work directed towards more targeted treatment of cancer, whether through more specific anti-cancer agents or through methods of delivery. These areas include delivery by avoiding the reticuloendothelial system, utilizing the enhanced permeability and retention effect and tumor-specific targeting. Treatment opportunities using antibody-targeted therapies are summarized. The ability to treat cancer by targeting delivery through angiogenesis is also discussed and antiangiogenic drugs in clinical trials are presented. Delivery methods that specifically use nanoparticles are also highlighted, including both degradable and nondegradable polymers.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15350294     DOI： 10.1016/j.addr.2004.02.014

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


  340 in total

1.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Authors:  Nagesh Kolishetti; Shanta Dhar; Pedro M Valencia; Lucy Q Lin; Rohit Karnik; Stephen J Lippard; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

3.  Silver nanosystems for photoacoustic imaging and image-guided therapy.

Authors:  Kimberly Homan; Jignesh Shah; Sobeyda Gomez; Heidi Gensler; Andrei Karpiouk; Lisa Brannon-Peppas; Stanislav Emelianov
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

Review 4.  Contrast-enhanced ultrasound for molecular imaging of angiogenesis.

Authors:  J R Eisenbrey; F Forsberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

5.  In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.

Authors:  Sumanta K Sahu; Sanjay K Mallick; Susmita Santra; Tapas K Maiti; Sudip K Ghosh; Panchanan Pramanik
Journal:  J Mater Sci Mater Med       Date:  2010-01-29       Impact factor: 3.896

Review 6.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

Review 7.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

8.  Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.

Authors:  A Preetha; N Huilgol; R Banerjee
Journal:  J Membr Biol       Date:  2007-08-22       Impact factor: 1.843

9.  Combined therapeutic efficacy of 188Re-liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26-luc murine colon cancer cells.

Authors:  Ya-Jen Chang; Wei-Hsin Hsu; Chih-Hsien Chang; Keng-Li Lan; Gann Ting; Te-Wei Lee
Journal:  Mol Clin Oncol       Date:  2014-01-20

10.  Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Authors:  Meenakshi Upreti; Azemat Jamshidi-Parsian; Scott Apana; Marc Berridge; Daniel A Fologea; Nathan A Koonce; Ralph L Henry; Robert J Griffin
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.